Details for New Drug Application (NDA): 212465
✉ Email this page to a colleague
The generic ingredient in MUPIROCIN is mupirocin. There are sixteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
Summary for 212465
Tradename: | MUPIROCIN |
Applicant: | Padagis Israel |
Ingredient: | mupirocin calcium |
Patents: | 0 |
Pharmacology for NDA: 212465
Mechanism of Action | RNA Synthetase Inhibitors |
Suppliers and Packaging for NDA: 212465
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 212465 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-018 | 45802-018-14 | 1 TUBE in 1 CARTON (45802-018-14) / 15 g in 1 TUBE |
MUPIROCIN | mupirocin calcium | CREAM;TOPICAL | 212465 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-018 | 45802-018-94 | 1 TUBE in 1 CARTON (45802-018-94) / 30 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | EQ 2% BASE | ||||
Approval Date: | Aug 3, 2022 | TE: | RLD: | No |
Complete Access Available with Subscription